Accrued Expenses

6 Months Ended

Jun. 30, 2024

Accrued Expenses

Accrued Expenses

Note 3. Accrued Expenses

The following is a summary of the Company’s accrued expenses:

	June 30,		December 31,
	2024		2023
Clinical trial expenses	$	1,356,608	$	1,993,784
Other		345,198		424,218
Total	$	1,701,806	$	2,418,002